316 related articles for article (PubMed ID: 31705294)
1. The comparison between adenocarcinoma and squamous cell carcinoma in lung cancer patients.
Wang BY; Huang JY; Chen HC; Lin CH; Lin SH; Hung WH; Cheng YF
J Cancer Res Clin Oncol; 2020 Jan; 146(1):43-52. PubMed ID: 31705294
[TBL] [Abstract][Full Text] [Related]
2. Population-based patterns of treatment and survival for patients with stage I and II non-small cell lung cancer aged 65-74 years and 75 years or older.
Driessen E; Detillon D; Bootsma G; De Ruysscher D; Veen E; Aarts M; Janssen-Heijnen M
J Geriatr Oncol; 2019 Jul; 10(4):547-554. PubMed ID: 30876833
[TBL] [Abstract][Full Text] [Related]
3. Non-small Cell Lung Cancer as a Chronic Disease - A Prospective Study from the Czech TULUNG Registry.
Bratova M; Karlinova B; Skrickova J; Pesek M; Kolek V; Koubkova L; Hrnciarik M; Krejci J; Barinova M; Havel L; Grygarkova I; Brat K
In Vivo; 2020; 34(1):369-379. PubMed ID: 31882501
[TBL] [Abstract][Full Text] [Related]
4. The Care and Outcomes of Older Persons with Lung Cancer in England and the United States, 2008-2012.
Andreano A; Peake MD; Janes SM; Valsecchi MG; Pritchard-Jones K; Hoag JR; Gross CP
J Thorac Oncol; 2018 Jul; 13(7):904-914. PubMed ID: 29727739
[TBL] [Abstract][Full Text] [Related]
5. Tumor spread through air spaces is a useful predictor of recurrence and prognosis in stage I lung squamous cell carcinoma, but not in stage II and III.
Yanagawa N; Shiono S; Endo M; Ogata SY
Lung Cancer; 2018 Jun; 120():14-21. PubMed ID: 29748009
[TBL] [Abstract][Full Text] [Related]
6. Survival Comparison in Patients with Stage IV Lung Cancer in Academic versus Community Centers in the United States.
Ramalingam S; Dinan MA; Crawford J
J Thorac Oncol; 2018 Dec; 13(12):1842-1850. PubMed ID: 30312680
[TBL] [Abstract][Full Text] [Related]
7. Treatment patterns and overall survival among patients with unresectable, stage III non-small-cell lung cancer.
Bobbili P; Ryan K; Duh MS; Dua A; Fernandes AW; Pavilack M; Gomez JE
Future Oncol; 2019 Oct; 15(29):3381-3393. PubMed ID: 31544510
[No Abstract] [Full Text] [Related]
8. Disparate outcomes in nonsmall cell lung cancer by immigration status.
Chau B; Ituarte PH; Shinde A; Li R; Vazquez J; Glaser S; Massarelli E; Salgia R; Erhunmwunsee L; Ashing K; Amini A
Cancer Med; 2021 Apr; 10(8):2660-2667. PubMed ID: 33734614
[TBL] [Abstract][Full Text] [Related]
9. Clinical impact of histologic type on survival and recurrence in patients with surgically resected stage II and III non-small cell lung cancer.
Yun JK; Kwon Y; Kim J; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI
Lung Cancer; 2023 Feb; 176():24-30. PubMed ID: 36580727
[TBL] [Abstract][Full Text] [Related]
10. Significance of
Kim E; Wu HG; Keam B; Kim TM; Kim DW; Paeng JC; Kim HJ; Chang JH
Clin Lung Cancer; 2019 Jan; 20(1):e9-e23. PubMed ID: 30266585
[TBL] [Abstract][Full Text] [Related]
11. Adenosquamous carcinoma of the lung: surgical results as compared with squamous cell and adenocarcinoma cases.
Maeda H; Matsumura A; Kawabata T; Suito T; Kawashima O; Watanabe T; Okabayashi K; Kubota I;
Eur J Cardiothorac Surg; 2012 Feb; 41(2):357-61. PubMed ID: 21737295
[TBL] [Abstract][Full Text] [Related]
12. Clinical features of large cell neuroendocrine carcinoma: a population-based overview.
Derks JL; Hendriks LE; Buikhuisen WA; Groen HJ; Thunnissen E; van Suylen RJ; Houben R; Damhuis RA; Speel EJ; Dingemans AM
Eur Respir J; 2016 Feb; 47(2):615-24. PubMed ID: 26541538
[TBL] [Abstract][Full Text] [Related]
13. Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC.
Kawaguchi T; Takada M; Kubo A; Matsumura A; Fukai S; Tamura A; Saito R; Maruyama Y; Kawahara M; Ignatius Ou SH
J Thorac Oncol; 2010 May; 5(5):620-30. PubMed ID: 20354456
[TBL] [Abstract][Full Text] [Related]
14. Worse lung cancer outcome in patients with lower respiratory tract infection confirmed at time of diagnosis.
Nagy A; Müller V; Kolonics-Farkas AM; Eszes N; Vincze K; Horvath G
Thorac Cancer; 2019 Sep; 10(9):1819-1826. PubMed ID: 31317672
[TBL] [Abstract][Full Text] [Related]
15. Lung cancer and prognosis in taiwan: a population-based cancer registry.
Wang BY; Huang JY; Cheng CY; Lin CH; Ko J; Liaw YP
J Thorac Oncol; 2013 Sep; 8(9):1128-35. PubMed ID: 23945383
[TBL] [Abstract][Full Text] [Related]
16. Retrospective Study of the Effect of Statins on the Outcome of Lung Cancer Patients, University of Cincinnati Experience.
Gaber O; Eldessouki I; Hassan R; Magdy M; Morris JC; Abdel Karim N
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2391-2396. PubMed ID: 31450911
[TBL] [Abstract][Full Text] [Related]
17. Difference in Postsurgical Prognostic Factors between Lung Adenocarcinoma and Squamous Cell Carcinoma.
Nakamura H; Sakai H; Kimura H; Miyazawa T; Marushima H; Saji H
Ann Thorac Cardiovasc Surg; 2017 Dec; 23(6):291-297. PubMed ID: 28966230
[TBL] [Abstract][Full Text] [Related]
18. Differences in patterns of recurrence of squamous cell carcinoma and adenocarcinoma after radiotherapy for stage III non-small cell lung cancer.
Katagiri Y; Jingu K; Yamamoto T; Matsushita H; Umezawa R; Ishikawa Y; Takahashi N; Takeda K; Tasaka S; Kadoya N
Jpn J Radiol; 2021 Jun; 39(6):611-617. PubMed ID: 33484424
[TBL] [Abstract][Full Text] [Related]
19. The Differences in Clinicopathologic and Prognostic Characteristics Between Surgically Resected Peripheral and Central Lung Squamous Cell Carcinoma.
Lin MW; Huang YL; Yang CY; Kuo SW; Wu CT; Chang YL
Ann Surg Oncol; 2019 Jan; 26(1):217-229. PubMed ID: 30456676
[TBL] [Abstract][Full Text] [Related]
20. Identification of potential serum biomarkers for simultaneously classifying lung adenocarcinoma, squamous cell carcinoma and small cell carcinoma.
Yu J; Du F; Yang L; Chen L; He Y; Geng R; Wu L; Xie B
Cancer Biomark; 2021; 30(3):331-342. PubMed ID: 33361584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
